ATLANTA, June 9 /PRNewswire-FirstCall/ -- For the fiscal year ending 2006 the Company reported a loss of $0.5 million or $(0.12) per diluted share compared to a profit of $11.5 million or $2.43 per diluted share for fiscal 2005. Net sales for fiscal 2006 declined 3.7% despite an increase in pounds marketed of 12.9%. The average market price for our products in fiscal 2006 decreased 18.7% from fiscal 2005. As a result of the additional pounds marketed, cost of sales increased 4.6%. However, cost of sales on a per pound marketed basis decreased 7.3% influenced by lower feed cost of 9.89% and various company wide operational efficiencies. This decrease was especially notable given the higher cost of energy and transportation experienced in fiscal 2006.
The fear of Avian Influenza abroad continues to impact our industry and Company. Cagle's participates in numerous preventive programs, both on the state and federal level, and has taken comprehensive measures at our facilities including testing of all flocks prior to slaughter as well as increased biosecurity to ensure against this disease.
We continue to explore marketing opportunities available as a result of the Company's focus on tender, smaller broilers. We believe that being fully dedicated to this small broiler program will allow us to better serve our target market segment of delicatessens and fast food providers as well as position the Company for a quick return to profitability as protein prices recover.
Cagle's Inc.
/s/ J. Douglas Cagle
J. Douglas Cagle
Chairman, CEO
Forward-Looking Statements:
Statements contained in this press release that state the intentions, hopes, beliefs, anticipations, expectations or predictions of the future of Cagle's Inc. and its management are forward looking statements. It is important to note that the actual results could differ materially from those projected. Factors that could cause actual results to differ materially from those project in such forward-looking statements include: additional outbreaks of avian influenza or other diseases affecting the production performance and/or marketability of the Company's poultry products; matters affecting the poultry industry in general, including fluctuations in the commodity prices of feed ingredients and chicken; contamination of our products leading to product liability claims and recalls; exposures to risks related to property damage and injuries to persons for which insurance is limited and potentially inadequate; management of our cash resources, particularly in light of our substantial leverage; trade barriers; changes in laws or regulations affecting our operations as well as competitive factors and pricing pressures; and the impact of uncertainties of litigations as well as other risk factors.
Cagle's Inc.
Consolidated Statements of Income
(in thousands except per share amounts)
Twelve Months Ended
April 1, 2006 April 2, 2005
Net Sales $237,266 $246,343
Cost and Expenses:
Cost of Sales 227,136 217,024
Selling & Delivery, General & Admin. 13,782 13,342
Total Cost and Expenses 240,918 230,366
Operating Profit (Loss) (3,652) 15,977
Other Income (Expense):
Interest Expense (2,407) (2,649)
Other Income (Expense), net 1,238 549
Total Other Income (Expense),net (1,169) (2,100)
Equity in Earnings of Unconsolidated Affiliates 3,957 4,129
Profit (Loss) before Income Taxes (864) 18,006
Income Tax Expense (Benefit) (290) 6,467
Net Profit (Loss) $(574) $ 11,539
Net Profit (Loss) per Share $(0.12) $2.43
Cagle's Inc.
Condensed Consolidated Balance Sheet
(in thousands)
ASSETS April 1, 2006 April 2, 2005
Current Assets $ 33,519 $ 32,687
Investments in Affiliates 8,740 6,105
Other Assets 9,493 11,000
Property, Plant, and Equipment (net) 43,452 44,500
TOTAL ASSETS $ 95,204 $ 94,292
LIABILITIES & STOCKHOLDER'S EQUITY
Current Maturities of Long-term Debt $3,645 $3,476
Trade Accounts Payable 14,516 11,563
Other Current Liabilities 5,942 6,438
Total Current Liabilities 24,103 21,477
Long-Term Debt 25,869 26,534
Other Non-current Liabilities - 475
Total Stockholder's Equity 45,232 45,806
TOTAL LIABILITIES & STOCKHOLDER'S EQUITY $ 95,204 $ 94,292
